Amgen

We are all different, yet we have this in common: our mission to serve patients. This sense of shared purpose is key to our becoming one of the world’s leading biotechnology companies. It guides us as we continue to launch new medicines and reach millions of patients worldwide.

We live the mission.

We win together.

We thrive on continual challenge.

Our team of 27,000+ scientists and professionals worldwide bring distinct perspectives and experiences to all we do. We leverage our global talent to achieve together—to research, manufacture and deliver ever-better products and greater depth to our mission.

At Amgen, there is a strong correlation between our high level of diversity and performance. Because addressing issues with a wider range of perspectives and approaches leads to more creative problem-solving. Together, we’re transforming the promise of science and biotechnology into therapies that have the power to restore health.

Connect with us to explore how you can Win, Live, and Thrive at Amgen.

AWARDS

Corporate Headquarters
One Amgen Center Drive
Thousand Oaks, CA 91320

Tel: 805-447-1000

Visit website

Email Us

LIVE. WIN. THRIVE.

We know an idea—any idea—can blossom into a lifesaving treatment. That’s why we dare to ask the questions most people won’t. Join us in pushing biotechnology.

Join Us

Employee Testimonials

“Amgen fosters a culture of innovation, with a science-based risk approach, centered in the benefit of our patients and powered by the diversity of our staff.”

Jorge D.
Porcess Scientific Director
Juncos, PR
“Cultivate your curiosity and continue to learn at Amgen — grow daily and explore career opportunities that align with your competencies and motivation”

Fernando F.
Executive Director Plant Manager
Rhode Island, US
“Working at Amgen, as Specialist Quality Control gives me the opportunity to work with Amgen products in benefit of the patients. Using my knowledge in science and share my diversity with my peers, is the best experience I have as part of the Amgen family.”

Niria R.
Specialist Quality Control
Juncos, PR

Diversity and Inclusion
Benefits
Community Investment
Awards and Accolades

Serving patients across the globe requires a global team. We continue building a diverse workforce that reflects the needs of those they serve, bringing with them innovative ideas that can push biotechnology forward.

Learn More

We offer more than benefits. Our Total Rewards Program secures the long-term financial, physical and overall well-being of you and your family. Among leading biotechnology and pharmaceutical leaders, we stand among the very best.

Learn More

Through Amgen Volunteers, you can dedicate eight hours to participating organizations of your choice. This along with matching employee donations to charities and our diverse corporate giving initiatives are just some ways you can make meaningful contributions as a global citizen

Learn More

Amgen is proud of the achievements we have realized as a mission-driven team—particularly the accolades we have earned as an employer. You can find our teams named in respected lists including Forbes, Fast Company and more.

Learn More

NEWS

Business

Biogen Increases Ownership in Samsung Bioepis

Cambridge, Massachusetts-based Biogen exercised its option to acquire additional shares of Samsung Bioepis, a joint venture with Samsung BioLogics that was founded in 2012.

June 29, 2018

3 min read

Mark Terry

Drug Development

Netherlands Biopharma Landscape Expected to Grow With the Arrival of the EMA

As the European Medicines Agency prepares to make Amsterdam its new home following the U.K.’s Brexit, Holland is likely to see its biopharma industry snag a hoped-for boost in new business due to the presence of the regulatory agency.

June 26, 2018

3 min read

Alex Keown

BioMidwest

Akero Therapeutics Launches with $65 Million Series A to Battle NASH

Akero Therapeutics, headquartered in Cambridge, Massachusetts, closed on a $65 million Series A financing round.

June 25, 2018

3 min read

Mark Terry

Deals

A Look at 6—Count ‘em, 6!—Biotech IPOs This Week

It’s a super-busy week for biotech initial public offerings (IPOs) with six companies raking in a total of around $568 million.

June 21, 2018

2 min read

Mark Terry

A shot of a senior man sitting on the sofa with his daughter, looking at a photograph. He is cuddling his daughter, looking sad and holding the photo.

Business

On “The Longest Day,” A Look at Alzheimer’s Clinical Trials

June is Alzheimer’s & Brain Awareness Month and June 21 is dubbed “The Longest Day,” which focuses on raising awareness of Alzheimer’s disease.

June 18, 2018

5 min read

Mark Terry

Aligos halted the production of therapy for Chroni

Drug Development

Teva Scraps Chronic Cluster Headache Study

Teva has a new headache. As the company pushes forward with its cost-cutting strategies, the company reported it is scrapping its chronic cluster headache program with fremanezumab.

June 15, 2018

2 min read

Alex Keown

Pharm Country

FDA Tells Mylan They Can’t (Yet) Approve its Generic to Advair

In a brief statement, Mylan reported that the U.S. Food and Drug Administration (FDA) had informed the company that its Generic Advair Diskus had “minor deficiencies” that would be in a Complete Response Letter.

June 14, 2018

2 min read

Mark Terry

Business

Billionaire Biotech Entrepreneur Patrick Soon-Shiong To Take New Cancer Company Public

Billionaire biotech entrepreneur Patrick Soon-Shiong has his eyes set on taking his newly formed oncology-focused Nant public this year.

June 11, 2018

2 min read

Alex Keown

Biotech Bay

California Life Science Sector Workforce Trends Report: Amgen, Pfizer and Genentech Leading Employers in the State

The Biocom Institute and California Life Sciences Institute (CLSI) released their third biennial life science industry report. Overall, the report paints a very positive picture of the life science industry in California.

June 6, 2018

4 min read

Mark Terry

JOBS